Wu Annie A, Drake Virginia, Huang Huai-Shiuan, Chiu ShihChi, Zheng Lei
Department of Oncology; The Johns Hopkins University School of Medicine ; Baltimore, MD USA.
School of Medicine; University of Maryland ; Baltimore, MD USA.
Oncoimmunology. 2015 Apr 1;4(7):e1016700. doi: 10.1080/2162402X.2015.1016700. eCollection 2015 Jul.
It has become evident that tumor-induced immuno-suppressive factors in the tumor microenvironment play a major role in suppressing normal functions of effector T cells. These factors serve as hurdles that limit the therapeutic potential of cancer immunotherapies. This review focuses on illustrating the molecular mechanisms of immunosuppression in the tumor microenvironment, including evasion of T-cell recognition, interference with T-cell trafficking, metabolism, and functions, induction of resistance to T-cell killing, and apoptosis of T cells. A better understanding of these mechanisms may help in the development of strategies to enhance the effectiveness of cancer immunotherapies.
很明显,肿瘤微环境中肿瘤诱导的免疫抑制因子在抑制效应T细胞的正常功能中起主要作用。这些因素成为限制癌症免疫疗法治疗潜力的障碍。本综述着重阐述肿瘤微环境中免疫抑制的分子机制,包括逃避T细胞识别、干扰T细胞运输、代谢及功能、诱导对T细胞杀伤的抗性以及T细胞凋亡。更好地理解这些机制可能有助于制定提高癌症免疫疗法有效性的策略。